Don't get left behind! The modernized is coming. Check it out now.
Say goodbye to!
The new site is coming soon - go to the modernized
Working… Menu

Impact of PCSK9 Inhibition on Clinical Outcome in Patients During the Inflammatory Stage of the COVID-19 (IMPACT-SIRIO 5)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04941105
Recruitment Status : Completed
First Posted : June 28, 2021
Last Update Posted : April 21, 2023
Information provided by (Responsible Party):
Jacek Kubica, Collegium Medicum w Bydgoszczy

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 17, 2022
Actual Study Completion Date : May 17, 2022